Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022

Prudden, Holly J.; Achilles, Sharon L.; Schocken, Celina; Broutet, Nathalie; Canfell, Karen; Akaba, Hiroki; Basu, Partha; Bhatla, Neerja; Chirenje, Z. Mike; Delany-Moretlwe, Sinead; Denny, Lynette; Gamage, Deepa G.; Herrero, Rolando; Hutubessy, Raymond; Villa, Luisa Lina; Murillo, Raul; Schiller, John T.; Stanley, Margaret; Temmerman, Marleen; Zhao, Fanghui; Ogilvie, Gina; Kaslow, David C.; Dull, Peter; Gottlieb, Sami L.; Therapeutic HPV Vaccine PPC Expert Consultation Group

dc.contributor.author	Prudden, Holly J.
dc.contributor.author	Achilles, Sharon L.
dc.contributor.author	Schocken, Celina
dc.contributor.author	Broutet, Nathalie
dc.contributor.author	Canfell, Karen
dc.contributor.author	Akaba, Hiroki
dc.contributor.author	Basu, Partha
dc.contributor.author	Bhatla, Neerja
dc.contributor.author	Chirenje, Z. Mike
dc.contributor.author	Delany-Moretlwe, Sinead
dc.contributor.author	Denny, Lynette
dc.contributor.author	Gamage, Deepa G.
dc.contributor.author	Herrero, Rolando
dc.contributor.author	Hutubessy, Raymond
dc.contributor.author	Villa, Luisa Lina
dc.contributor.author	Murillo, Raul
dc.contributor.author	Schiller, John T.
dc.contributor.author	Stanley, Margaret
dc.contributor.author	Temmerman, Marleen
dc.contributor.author	Zhao, Fanghui
dc.contributor.author	Ogilvie, Gina
dc.contributor.author	Kaslow, David C.
dc.contributor.author	Dull, Peter
dc.contributor.author	Gottlieb, Sami L.
dc.contributor.author	Therapeutic HPV Vaccine PPC Expert Consultation Group
dc.coverage.temporal	2021-2022	spa
dc.date.accessioned	2023-03-17T19:27:51Z
dc.date.accessioned	2023-05-11T17:06:04Z
dc.date.available	2023-03-17T19:27:51Z
dc.date.available	2023-05-11T17:06:04Z
dc.date.created	2022-08-22
dc.identifier	https://www.sciencedirect.com/science/article/pii/S0264410X22009999?via%3Dihub	spa
dc.identifier.issn	0264-410X / 1873-2518 (Electrónico)	spa
dc.identifier.uri	https://hdl.handle.net/20.500.12032/103836
dc.format	PDF	spa
dc.format.mimetype	application/pdf	spa
dc.language.iso	eng	spa
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	*
dc.title	Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022	spa

Arquivos deste item

Arquivos	Tamanho	Formato	Visualização
Understanding t ... ctober 2021—March 2022.pdf	1.856Mb	application/pdf	Visualizar/Abrir

Este item aparece na(s) seguinte(s) coleção(s)

Documentos - PUJB

Mostrar registro simples

Exceto quando indicado o contrário, a licença deste item é descrito como http://creativecommons.org/licenses/by-nc/4.0/